Pacific Biosciences of California, Inc. (PACB)
NASDAQ: PACB · Real-Time Price · USD
1.520
-0.100 (-6.17%)
At close: Mar 3, 2026, 4:00 PM EST
1.520
0.00 (0.00%)
After-hours: Mar 3, 2026, 4:34 PM EST
PACB Stock Forecast
Stock Price Forecast
The 5 analysts with 12-month price forecasts for PACB stock have an average target of 2.20, with a low estimate of 2.00 and a high estimate of 3.00. The average target predicts an increase of 44.74% from the current stock price of 1.52.
Analyst Consensus: Buy
* Price targets were last updated on Dec 15, 2025.
Analyst Ratings
The average analyst rating for PACB stock from 5 stock analysts is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Sep '25 | Oct '25 | Nov '25 | Dec '25 | Jan '26 | Feb '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 1 | 1 | 1 | 1 | 1 | 1 |
| Buy | 2 | 2 | 2 | 2 | 2 | 2 |
| Hold | 5 | 5 | 4 | 3 | 3 | 2 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 8 | 8 | 7 | 6 | 6 | 5 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Barclays | Barclays | Hold Maintains $1.5 → $2 | Hold | Maintains | $1.5 → $2 | +31.58% | Dec 15, 2025 |
| Piper Sandler | Piper Sandler | Hold Maintains $1.5 → $2 | Hold | Maintains | $1.5 → $2 | +31.58% | Nov 11, 2025 |
| Stephens & Co. | Stephens & Co. | Buy Maintains $1.8 → $2 | Buy | Maintains | $1.8 → $2 | +31.58% | Nov 10, 2025 |
| Piper Sandler | Piper Sandler | Hold Maintains $1.25 → $1.5 | Hold | Maintains | $1.25 → $1.5 | -1.32% | Aug 11, 2025 |
| Barclays | Barclays | Hold Maintains $2 → $1.5 | Hold | Maintains | $2 → $1.5 | -1.32% | Jun 25, 2025 |
Financial Forecast
Revenue This Year
179.94M
from 160.01M
Increased by 12.46%
Revenue Next Year
201.71M
from 179.94M
Increased by 12.10%
EPS This Year
-0.53
from -1.82
EPS Next Year
-0.49
from -0.53
Revenue Forecast
| Revenue | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|
| High | 190.1M | 212.3M | |||
| Avg | 179.9M | 201.7M | |||
| Low | 169.3M | 188.2M |
Revenue Growth
| Revenue Growth | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|
| High | 18.8% | 18.0% | |||
| Avg | 12.5% | 12.1% | |||
| Low | 5.8% | 4.6% |
EPS Forecast
| EPS | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|
| High | -0.45 | -0.47 | |||
| Avg | -0.53 | -0.49 | |||
| Low | -0.56 | -0.50 |
EPS Growth
| EPS Growth | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|
| High | - | - | |||
| Avg | - | - | |||
| Low | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.